U.S. Markets open in 4 hrs 4 mins

Ortho Clinical Diagnostics Holdings plc (OCDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
22.31+0.10 (+0.45%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close22.21
Open22.14
Bid17.99 x 900
Ask0.00 x 1100
Day's Range21.83 - 22.71
52 Week Range15.14 - 22.71
Volume452,741
Avg. Volume1,099,266
Market Cap5.409B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est24.73
  • ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico
    CNW Group

    ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico

    Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO OPTIX™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected of an automated platform, is now available in the United States and Puerto Rico.

  • PR Newswire

    Ortho Clinical Diagnostics Simultaneously Launches First Quantitative COVID-19 IgG Spike Antibody Test As Well As A Nucleocapsid Antibody Test to Help Differentiate Cause of Antibody Response

    Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the launch of the first quantitative COVID-19 IgG antibody test in addition to a total COVID-19 nucleocapsid antibody test.

  • GlobeNewswire

    Ortho Clinical Diagnostics to Present at Upcoming Investor Conferences

    RARITAN, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that members of its management team are scheduled to present in two upcoming investor conferences: UBS Virtual Global Healthcare Conference on Monday, May 24, 2021 at 11:00am ETGoldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 1:30pm ET Interested parties can access a live webcast and replay of each presentation on the “Investors” portion of the Company’s website at https://ir.orthoclinicaldiagnostics.com/, under the “Events” section. Management will also be hosting individual meetings with investors at both of the conferences. About Ortho Clinical Diagnostics Ortho Clinical Diagnostics (Nasdaq: OCDX) is one of the world’s largest pure-play in vitro diagnostics (IVD) companies. More than 800,000 patients across the world are impacted by Ortho’s tests each day. Because Every Test is a Life™, Ortho provides hospitals, hospital networks, clinical laboratories and blood banks around the world with innovative technology and tools to ensure test results are fast, accurate, and reliable. Ortho's customized solutions enhance clinical outcomes, improve efficiency, overcome lab staffing challenges and reduce costs. From launching the first product to determine Rh+ or Rh- blood type, developing the world’s first tests for the detection of antibodies against HIV and hepatitis C, introducing patented dry-slide technology and marketing the first U.S. Food and Drug Administration-authorized high-volume antibody and antigen tests for COVID-19, Ortho has been a pioneering leader in the IVD space for over 80 years. The company is powered by Ortho Care™, an award-winning, holistic service and support program that ensures best-in-class technical, field and remote service and inventory support to laboratories in more than 130 countries and territories around the globe. For more information, visit Ortho’s website or social media channels: LinkedIn, Twitter, Facebook and YouTube. Investors: IR@orthoclinicaldiagnostics.com Media: media@orthoclinicaldiagnostics.com